SCHEMBL6301738

SCHEMBL6301738

O=[N+]([O-])c1ccc(S(=O)(=O)Nc2cncc(Cl)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.49
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
KDM1A O60341 1/20 0.47
PIK3CB P42338 1/20 0.47
KMT2A Q03164 4/20 0.47
MAPK1 P28482 2/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CDK2 P24941 1/20 0.47
CA1 P00915 3/20 0.47
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP13 P45452 1/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6302286 0.82 LMNA (0.55) CA2CA12CA9KDM1AKMT2A
Sulfaclozine SCHEMBL29393580 0.81 LMNA (0.60) MAPTNPSR1CDK2SMN1; SMN2
Sulfaclozine SCHEMBL2109909 0.81 LMNA (0.60) MAPTNPSR1CDK2SMN1; SMN2
SCHEMBL925179 0.81 GAA (0.58) PIK3CBKMT2ANPSR1CDK2MEN1
Sulfaclozine SCHEMBL31317653 0.80 LMNA (0.58) MAPTNPSR1CDK2SMN1; SMN2
Sulfaclozine SCHEMBL28407148 0.79 LMNA (0.57) MAPTNPSR1CDK2SMN1; SMN2
SCHEMBL29225745 0.75 KMT2A (0.52) CA2CA12CA9KDM1AKMT2A
SCHEMBL30913863 0.75 KMT2A (0.52) CA2CA12CA9KDM1AKMT2A
SCHEMBL9703345 0.74 LMNA (0.69) CA2CA12CA9KMT2AMAPK1
SCHEMBL6301737 0.73 F2 (0.44) CA2CA12CA9KDM1APIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230235-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES New Pharma Research Sweden AB (SE) 2002-08-14 EP claimed
WO-2001036408-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES NEW PHARMA RESEARCH SWEDEN AB (SE) 2001-05-25 WO claimed
US-6967205-B1 Compounds with antibacterial and antiparasitic properties NEW PHARMA RESEARCH SWEDEN AB (SE) 2005-11-22 US disclosed
EP-1230235-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES New Pharma Research Sweden AB (SE) 2002-08-14 EP disclosed
WO-2001036408-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES NEW PHARMA RESEARCH SWEDEN AB (SE) 2001-05-25 WO disclosed